Comments to FDA: External Analgesic Drug Products for OTC Human Use Share page: Docket Number: 78N-0301 In this submission the task group provides updated data on the safety of counterirritants administered via patched or other novel dosage forms. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Responds to HHS/FDA Announcement to Phase Out Petroleum-based Synthetic Dyes from America’s Food Supply Apr 22, 2025 Press Releases and Statements Health In Hand Foundation Announces Call for Nominations: 2025 U.S. Self-Care Marketing Awards Apr 22, 2025 Press Releases and Statements CHPA Applauds White House Executive Order Prioritizing Lower Drug Costs and Access to Self-Care Apr 17, 2025